Katarzyna Furrer
Extended resection for potentially operable patients with stage III non-small cell lung cancer after induction treatment.
Furrer K, Weder W, Eboulet E, Betticher D, Pless M, Stupp R, Krueger T, Perentes J, Schmid R, Lardinois D, Furrer M, Früh M, Peters S, Curioni-Fontecedro A, Stahel R, Rothschild S, Hayoz S, Opitz I. Extended resection for potentially operable patients with stage III non-small cell lung cancer after induction treatment. J Thorac Cardiovasc Surg 2022; 164:1587-1602.e5.
Apr 18, 2022Extended resection for potentially operable patients with stage III non-small cell lung cancer after induction treatment.
Apr 18, 2022J Thorac Cardiovasc Surg 2022; 164:1587-1602.e5
Furrer Katarzyna, Weder Walter, Eboulet Eric Innocents, Betticher Daniel, Pless Miklos, Stupp Roger, Krueger Thorsten, Perentes Jean Yannis, Schmid Ralph A, Lardinois Didier, Furrer Markus, Früh Martin, Peters Solange, Curioni-Fontecedro Alessandra, Stahel Rolf A, Rothschild Sacha I, Hayoz Stefanie, Opitz Isabelle
Long-term outcomes of operable stage III NSCLC in the pre-immunotherapy era: results from a pooled analysis of the SAKK 16/96, SAKK 16/00, SAKK 16/01, and SAKK 16/08 trials.
König D, Scharl S, Vuong D, Guckenberger M, Furrer K, Opitz I, Weder W, Rothschild S, Ochsenbein A, Zippelius A, Addeo A, Mark M, Eboulet E, Hayoz S, Thierstein S, Betticher D, Ris H, Stupp R, Curioni-Fontecedro A, Peters S, Pless M, Früh M. Long-term outcomes of operable stage III NSCLC in the pre-immunotherapy era: results from a pooled analysis of the SAKK 16/96, SAKK 16/00, SAKK 16/01, and SAKK 16/08 trials. ESMO Open 2022; 7:100455.
Apr 7, 2022Long-term outcomes of operable stage III NSCLC in the pre-immunotherapy era: results from a pooled analysis of the SAKK 16/96, SAKK 16/00, SAKK 16/01, and SAKK 16/08 trials.
Apr 7, 2022ESMO Open 2022; 7:100455
König D P, Scharl Sylvie, Vuong D, Guckenberger M, Furrer Katarzyna, Opitz Isabella, Weder W, Rothschild S I, Ochsenbein A, Zippelius A, Addeo Alfredo, Mark M, Eboulet E I, Hayoz S, Thierstein S, Betticher D C, Ris H-B, Stupp R, Curioni-Fontecedro A, Peters S, Pless M, Früh M
Serotonin reverts age-related capillarization and failure of regeneration in the liver through a VEGF-dependent pathway
Furrer K, Moritz W, Graf R, Humar B, Käch A, Bittermann A, Jochum W, Tian Y, Rickenbacher A, Clavien P. Serotonin reverts age-related capillarization and failure of regeneration in the liver through a VEGF-dependent pathway. Proc Natl Acad Sci USA 2011; 108:2945-50.
Jan 31, 2011Serotonin reverts age-related capillarization and failure of regeneration in the liver through a VEGF-dependent pathway
Jan 31, 2011Proc Natl Acad Sci USA 2011; 108:2945-50
Furrer Katarzyna, Moritz Wolfgang, Graf Rolf, Humar Bostjan, Käch Andres, Bittermann Anne Greet, Jochum Wolfram, Tian Yinghua, Rickenbacher Andreas, Clavien Pierre-Alain
Selective portal vein embolization and ligation trigger different regenerative responses in the rat liver
Furrer K, Tian Y, Pfammatter T, Jochum W, El-Badry A, Graf R, Clavien P. Selective portal vein embolization and ligation trigger different regenerative responses in the rat liver. Hepatology (Baltimore, Md.) 2008; 47:1615-23.
May 1, 2008Selective portal vein embolization and ligation trigger different regenerative responses in the rat liver
May 1, 2008Hepatology (Baltimore, Md.) 2008; 47:1615-23
Furrer Katarzyna, Tian Yinghua, Pfammatter Thomas, Jochum Wolfram, El-Badry Ashraf Mohammad, Graf Rolf, Clavien Pierre-Alain